// App-Quantinova.ai

: Apabetalone (RVX-208) Attenuates an Inflammatory Milieu that Enhances Adhesion of Monocytes to Endothelial Cells in Type 2 Diabetes Mellitus with Cardiovascular Disease Patients

Researchers

Presenter

  • LAURA TSUJIKAWA

Principal Investigators

  • EWELINA KULIKOWSKI

  • CYRUS CALOSING

  • SYLWIA WASIAK

  • DEAN GILHAM

  • CHRISTOPHER HALLIDAY

  • JAN O. JOHANSSON

  • MICHAEL SWEENEY

Medical Centers

  • N/A

Locations

  • Canada

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Endocrine/metabolic Diseases (ME)

Disease

  • Type 2 diabetes mellitus

Biomarkers

  • Integrin alpha-4

  • E-selectin

  • Interleukin 6

  • Vascular cell adhesion molecule 1

Drug/Treatment

  • RVX-208

Outcome

  • N/A

Study Design

  • Placebo Control

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved